scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1083720050 |
P356 | DOI | 10.1186/S13027-017-0119-8 |
P932 | PMC publication ID | 5297093 |
P698 | PubMed publication ID | 28191032 |
P50 | author | Alessandro Perrella | Q45468143 |
P2093 | author name string | A Lanza | |
A Nappi | |||
C Sbreglia | |||
A Izzi | |||
P Bellopede | |||
M Spatarella | |||
P2860 | cites work | Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence | Q29616009 |
Diagnosis, management, and treatment of hepatitis C: an update | Q29619682 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
Hepatitis C virus infection trends in Italy | Q35819921 | ||
The changing epidemiology of hepatitis C virus infection in Europe | Q37006042 | ||
Novel therapies for hepatitis C: insights from the structure of the virus | Q37937583 | ||
Interferon-free, direct-acting antiviral therapy for chronic hepatitis C. | Q38530211 | ||
Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy | Q38703524 | ||
Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older | Q40171094 | ||
Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C. | Q41728099 | ||
APASL consensus statements and recommendation on treatment of hepatitis C. | Q42400012 | ||
Prevention of hepatitis C in Italy: lessons from surveillance of type-specific acute viral hepatitis | Q62579354 | ||
Myo-pericarditis secondary to ledipasvir-sofosbuvir therapy | Q87155509 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 12 | |
P577 | publication date | 2017-02-07 | |
P1433 | published in | Infectious Agents and Cancer | Q15814259 |
P1476 | title | Safety of new DAAs for chronic HCV infection in a real life experience: role of a surveillance network based on clinician and hospital pharmacist | |
P478 | volume | 12 |
Q41108422 | Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study |
Q58698597 | Role of a clinical pharmacist as part of a multidisciplinary care team in the treatment of HCV in patients living with HIV/HCV coinfection |
Search more.